CVS Health Corporation (CVS)
Should You Buy CVS Health Stock Before Feb. 12?
CVS Health (CVS 2.01%) is a big name in healthcare, and it has generally been seen as a good way to invest in the industry. In addition to its pharmacy retail operations, the company has a pharmacy benefits management business.
Is Most-Watched Stock CVS Health Corporation (CVS) Worth Betting on Now?
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Momentum Grows for These 3 Healthcare Stocks
Today's stock market has brought about a set of distracting indicators and methods to analyze a potential trade—or investment—opportunity, some of which might be accurate in a completely binary setting. What most investors fail to realize is that all of these indicators and methods rely on price action, which is why today's list cuts down all the noise to focus on one indicator alone.
CVS Health (CVS) Increases Despite Market Slip: Here's What You Need to Know
In the latest trading session, CVS Health (CVS) closed at $54.55, marking a +1.36% move from the previous day.
Walgreens Boots Alliance vs. CVS Health: What's the Better Turnaround Play?
Investing in pharmacy chains hasn't been a good move in recent years. Rite Aid filed for (and emerged from) bankruptcy, and while its larger rivals aren't in as dire shape, they aren't exactly flourishing.
Wall Street Analysts See CVS Health (CVS) as a Buy: Should You Invest?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
CVS Health Isn't Going To The Dogs
CVS Health's poor 2024 performance was driven by negative macro and micro factors. Investors became too pessimistic about the company's forward prospects. A new CEO is a catalyst. Despite weak 2024 financial results, CVS is likely to begin to rebound in 2025. The company remains free cash flow positive, despite myriad challenges.
CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights
CVS Health (CVS) reachead $51.96 at the closing of the latest trading day, reflecting a -0.35% change compared to its last close.
3 Dividend Stocks at Bargain Levels to Defend Your Portfolio
As 2025 kicks off with a volatile start, many investors are likely feeling the pressure of heightened uncertainty. The S&P 500 and other major indices are down year-to-date, led by sharp declines in tech heavyweights like NVIDIA, which has fallen 13% from its 52-week high set just days ago.
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Big Gains Ahead for Medicare Advantage Sellers as Payments Set to Grow
As the largest MA plan sellers, UnitedHealth, Humana and CVS Health collectively account for nearly 60% of the market.
CVS Health stock price rises after Walgreens earnings: is it a buy?
The CVS Health stock price rebounded to $48 on Monday, up 10% from its lowest in December. This rebound continued after the strong Walgreens Boots Alliance earnings, which pushed the stock up almost 50% from its lowest point in 2024.
